On 30 June 2021, a draft bill amending the Act of 12 May 2011 on the Reimbursement of Medicines, Foodstuffs for Special Nutritional...

The Portuguese Parliament will meet to debate two draft-laws aimed at legalizing cannabis for non-medical personal use.

Both draft-laws...

On 21 April 2021, the European Commission published the long-awaited proposal for a Regulation on Artificial Intelligence[1](“AI...

The European Commission is currently working out a Digital Green Certificate mechanism with the eHealth Network. The setting-up of this...

The Medicines and Medical Devices Act 2021 (the “MMD Act”) was granted royal assent on 11th February 2021. The MMD Act confers broad...

The IPHA has updated its self-governance and advertising codes; key updates for those in the pharma sector.

The Irish Pharmaceutical...

On 23 February 2021, an update was published to the British Medicines and Healthcare products Regulatory Agency's (MHRA) Guidance on the...

Significant technological and scientific development over the last few years has shown that the EU’s framework on blood, tissues and cells (

The Australian Pharmaceutical Benefits Advisory Committee (PBAC) has amended its process for reviewing positive PBAC recommendations that...

The Australian Therapeutic Goods Administration (TGA) is currently conducting a public consultation into the “repurposing” of...

When the Covid-19 pandemic hit Europe in 2020, the Portuguese Government took the opportunity to establish the health sector as a...

In this month's 'Russia Pharmaceuticals Sector Update', Julien Hansen, Elena Mikhailovskaia and Pavel Arievich of DLA Piper's Moscow...

The House of Lords Science and Technology Committee's inquiry into "Life Sciences and the Industrial Strategy" is fascinating.  Last...